Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis
- 1 January 2021
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 209, 112942
Abstract
No abstract availableKeywords
Funding Information
- Tehran University of Medical Sciences and Health Services (98-3-104-45990, 962567)
- National Institute for Medical Research Development (98-3-104-45990, 962567)
This publication has 29 references indexed in Scilit:
- In Silico Discovery of Potential VEGFR-2 Inhibitors from Natural Derivatives for Anti-Angiogenesis TherapyInternational Journal of Molecular Sciences, 2014
- Biphenyl derivatives incorporating urea unit as novel VEGFR-2 inhibitors: Design, synthesis and biological evaluationBioorganic & Medicinal Chemistry, 2014
- Molecular Dynamics Simulation of VEGFR2 with Sorafenib and Other Urea-Substituted Aryloxy CompoundsJournal of Theoretical Chemistry, 2013
- Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New InhibitorsJournal of Medicinal Chemistry, 2012
- SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth In VivoClinical Cancer Research, 2011
- The chick embryo chorioallantoic membrane as a model to study tumor metastasisAngiogenesis, 2008
- Tissue Factor in Cancer and Angiogenesis: The Molecular Link between Genetic Tumor Progression, Tumor Neovascularization, and Cancer CoagulopathySeminars in Thrombosis and Hemostasis, 2006
- The biology of VEGF and its receptorsNature Medicine, 2003
- Heterocyclen aus CH‐aciden Nitrilen, XIV. 2‐Amino‐thionaphtheneEuropean Journal of Inorganic Chemistry, 1968
- Heterocyclen aus CH‐aciden Nitrilen, VIII. 2‐Amino‐thiophene aus methylenaktiven Nitrilen, Carbonylverbindungen und SchwefelEuropean Journal of Inorganic Chemistry, 1966